Use of sodium–glucose cotransporter 2 inhibitors in Alberta adults with chronic kidney disease: a cross-sectional study identifying care gaps to inform knowledge translation-Reference-Cited by-同舟云学术

Use of sodium–glucose cotransporter 2 inhibitors in Alberta adults with chronic kidney disease: a cross-sectional study identifying care gaps to inform knowledge translation

Published:2023-01 Issue:1 Volume:11 Page:E101-E109
ISSN:2291-0026
Container-title:CMAJ Open
language:en
Short-container-title:cmajo

Author:

Lau Darren,Pannu Neesh,Yeung Roseanne O.,Scott-Douglas Nairne,Klarenbach Scott

Publisher

CMA Impact Inc.

Subject

General Medicine

Reference33 articles.

1. Cause of Death in Patients with Reduced Kidney Function

2. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

3. Dapagliflozin in Patients with Chronic Kidney Disease

4. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

5. Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update;Lipscombe;Can J Diabetes,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium‐glucose co‐transporter‐2 inhibitors: Writing the next chapter of a unique success story;Diabetes, Obesity and Metabolism;2024-09-02

2. Basal Insulin Initiation in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study Using Administrative Health Data in Alberta, Canada;Canadian Journal of Diabetes;2024-08

3. Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD;Journal of the American Society of Nephrology;2024-07-29

4. Prescription Patterns of Sodium-glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes and Heart Failure With Reduced Ejection Fracture Admitted to a Tertiary Care Centre in Ontario, Canada;Canadian Journal of Diabetes;2024-07

5. Real-Time Use of SGLT2i Verified in Pre-dialysis: The RSVP Cross-sectional Study;Annals of Pharmacotherapy;2024-05-12